Using whole exome sequencing, Grossman et al studied CN-AML patients with no mutation in NPM1, CEBPA, FLT3-ITD, IDH and MLL-PTD genes (AML index patients). The gene discussed is KMT2A; the disease is acute myeloid leukemia.